Resultados de la búsqueda 1-10 of 4670 for pharmacogenetics
Mayo Clinic Department of Clinical Genomics uses genomic testing to personalize care. Our experts develop knowledge about a person's DNA to help predict, ...
The Mayo Clinic Congenital Disorders of Glycosylation (CDG) Clinic sees more patients with CDG than any other practice in the U.S. Mayo Clinic specialists ...
Pharmacogenetics and Genomics. 2013;23:535. Tantisira K, et al. Overview of pharmacogenomics. https://www.uptodate.com/contents/search. Accessed May 17 ...
Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more ...
Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...
Page 1.
The purpose of this study is to evaluate olaparib and temozolomide in treating patients with uterine leiomyosarcoma (LMS) that has spread to other places of ...
Rochester, Minn. This research trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be ...
This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, ...
The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer. T cells fight infections and, in some cases, can also kill ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?